Home India Ministry of Health and Family Welfare To allow import of Oxytocin API for manufacture of formulati...
Date: 2021-10-27 Category: Extra Ordinary State: Union Government Country: India

To allow import of Oxytocin API for manufacture of formulation for export purpose only

Issued by Ministry of Health and Family Welfare · Department of Health and Family Welfare

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

This notification, G.S.R. 762(E), issued by the Ministry of Health and Family Welfare, Department of Health and Family Welfare, amends notification G.S.R. 577(E), dated July 23, 1983, under the authority of Section 10A of the Drugs and Cosmetics Act, 1940 (23 of 1940). The amendment pertains to serial number 12 in the Table of the principal notification, inserting the words "and Oxytocin Active Pharmaceutical Ingredient API imported exclusively to manufacture formulations for the purpose of export only" after the words "test and analysis." The notification is dated October 27, 2021, and is referenced as F. No. X.11014/2/2018-DR. The issuing authority is Dr. Mandeep K. Bhandari, Jt. Secy.

Key Entities Referenced

Drugs and Cosmetics Act, 1940: A law that empowers the Central Government to regulate drugs and cosmetics in India. Ministry of Health and Family Welfare: The government ministry responsible for health policy in India. Central Government: The executive authority of the Union of India. New Delhi: The capital of India, located in Delhi. Oxytocin Active Pharmaceutical Ingredient API: A specific drug ingredient, Oxytocin API, that is subject to regulations regarding import and export. G.S.R. 577E: A notification number related to amendments within the Gazette of India. G.S.R. 180E: A notification number related to amendments within the Gazette of India. Dr. Mandeep K. Bhandari: Joint Secretary within the Ministry of Health and Family Welfare.
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 xxxGIDHxxx सी.जी.-डी.एxलx.x-GअID.-E2xx7x1 02021-230773 CG-DL-E-27102021-230773 ऄसाधारण EXTRAORDINARY भाग II—खण् ड 3—उप-खण्ड (i) PART II—Section 3—Sub-section (i) प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 616] नई ददल्ली, बुधवार, ऄक्त बू र 27, 2021/कार्मतक 5, 1943 No. 616] NEW DELHI, WEDNESDAY, OCTOBER 27, 2021/KARTIKA 5, 1943 स्ट्वास्ट््य और पररवार कल्याण मत्रं ालय (स्ट्वास्ट््य और पररवार कल्याण जवभाग) ऄजधसचू ना नई ददल्ली, 27 ऄक् तूबर, 2021 सा.का.जन. 762(ऄ).—केन्द्रीय सरकार, औषजध और प्रसाधन सामग्री ऄजधजनयम, 1940 (1940 का 23) की धारा 10क के द्वारा प्रदत्त िजियों का प्रयोग करत े हुए, भारत सरकार के स्ट् वास्ट् ् य और पररवार कल् याण मंत्रालय की ऄजधसूचना संखयांक सा.का.जन. 577(ऄ), तारीख 23 िलु ाई, 1983 म ें और संिोधन करन े के जलए जनम्नजलजखत संिोधन करती ह,ै ऄथाात:— उि ऄजधसूचना की सारणी म,ें क्रम संखयांक 12 की प्रजवजि म,ें “जनदेि मानकों” िब्दों के पश्चात्, जनम्नजलजखत िब्द और ऄक्षर ऄंतःस्ट्थाजपत दकए िाएंगे, ऄथाता :— “और केवल जनयाात के प्रयोिन से जवजनर्ममजत के जवजनमााण के जलए ऄनन्द्य रूप से अयात दकए गए ऑक्सीटोजसन सदक्रय औषध संघटक (एपीअई)” [फा.सं. एक्स.11014/2/2018-डीअर] डॉ. मनदीप के. भण् डारी, संयुक् त सजचव रटप्पण: मूल ऄजधसूचना भारत के रािपत्र, ऄसाधारण, भाग II, खंड 3, उपखंड (i) में ऄजधसचू ना सं. सा.का.जन. 577(ऄ), तारीख 23 िलु ाई, 1983 द्वारा प्रकाजित की गई थी और उसमें ऄंजतम बार संिोधन ऄजधसूचना सं. सा.का.जन. 180(ऄ), तारीख 16 माचा, 2020 द्वारा दकया गया। 6211 GI/2021 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)] MINISTRY OF HEALTH AND FAMILY WELFARE (Department of Health and Family Welfare) NOTIFICATION New Delhi, the 27th October, 2021 G.S.R. 762(E).―In exercise of the powers conferred by section 10A of the Drugs and Cosmetics Act, 1940 (23 of 1940), the Central Government hereby makes the following amendment further to amend the notification of the Government of India in the Ministry of Health and Family Welfare, number G.S.R. 577(E), dated the 23rd July, 1983, namely:― In the said notification, in the Table, in the entry at serial number 12, after the words “test and analysis”, the following words and letters shall be inserted, namely:― "and Oxytocin Active Pharmaceutical Ingredient (API) imported exclusively to manufacture formulations for the purpose of export only”. [F. No. X.11014/2/2018-DR] Dr. MANDEEP K. BHANDARI, Jt. Secy. Note: The principal notification was published in the Gazette of India, Extraordinary, Part II, Section3, Sub-section (i) vide G.S.R. 577(E), dated the 23rd July, 1983 and lastly amended vide notification number G.S.R. 180(E), dated the 16th March, 2020. Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research